SingHealth and Singapore Innovate have agreed to a three-year agreement to accelerate the development and deployment of artificial intelligence and other new technologies in Singapore to improve diagnoses, treatment, healthcare delivery, and clinical outcomes. SingHealth will combine its strong clinical research skills and pool of clinicians and healthcare innovators with SGInnovate’s deep technology knowledge and a varied network of corporates, startups, and innovators, according to a news release.
They will concentrate on three primary areas: expanding AI thought leadership, supporting the growth and innovation of health and biomedical research firms, and developing a talent pool for health innovation. To foster AI thought leadership, a Community of Practice will be established that will connect the networks of both organisations on a regular basis. Quarterly AI and Digital Innovation Journal Clubs are held, as well as a yearly AI in Health workshop. To assist the firms’ growth and innovations, educational and engagement efforts such as panels, roundtables, and reverse pitches will be supported.
The adoption of new healthcare technologies such as AI, according to SingHealth Group CEO Ivy Ng, is “essential for the future of medicine” in order to optimise resources and create a robust healthcare system that reacts to changing patient requirements. Dr Lim Jui, the CEO of SGInnovate, also stated that “much more” needs to be done in order to transfer discoveries in healthcare and biomedical sciences research into “impactful solutions.”